These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37161965)

  • 61. Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases.
    Wang C; Sandhu J; Ouyang C; Ye J; Lee PP; Fakih M
    JAMA Netw Open; 2021 Aug; 4(8):e2118416. PubMed ID: 34369992
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues.
    Brunner PM; Emerson RO; Tipton C; Garcet S; Khattri S; Coats I; Krueger JG; Guttman-Yassky E
    Allergy; 2017 Dec; 72(12):2017-2025. PubMed ID: 28599078
    [TBL] [Abstract][Full Text] [Related]  

  • 63. T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors.
    Simnica D; Akyüz N; Schliffke S; Mohme M; V Wenserski L; Mährle T; Fanchi LF; Lamszus K; Binder M
    Oncoimmunology; 2019; 8(11):e1644110. PubMed ID: 31646093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of CTLA-4 blockade and interferon-α on clonality of T-cell repertoire in the tumor microenvironment and peripheral blood of metastatic melanoma patients.
    Khunger A; Rytlewski JA; Fields P; Yusko EC; Tarhini AA
    Oncoimmunology; 2019; 8(11):e1652538. PubMed ID: 31646098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial.
    Coffman-D'Annibale K; Myojin Y; Monge C; Xie C; Hrones DM; Wood BJ; Levy EB; Kleiner D; Figg WD; Steinberg SM; Redd B; Greten TF
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38184304
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
    Benítez R; Yu K; Sirota M; Malats N; Pineda S
    Front Immunol; 2023; 14():986598. PubMed ID: 36817478
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4
    Zhu W; Germain C; Liu Z; Sebastian Y; Devi P; Knockaert S; Brohawn P; Lehmann K; Damotte D; Validire P; Yao Y; Valge-Archer V; Hammond SA; Dieu-Nosjean MC; Higgs BW
    Oncoimmunology; 2015 Dec; 4(12):e1051922. PubMed ID: 26587322
    [TBL] [Abstract][Full Text] [Related]  

  • 68. T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
    Lin KR; Deng FW; Jin YB; Chen XP; Pan YM; Cui JH; You ZX; Chen HW; Luo W
    Cancer Med; 2018 Aug; 7(8):3755-3762. PubMed ID: 29947152
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Application and challenges of TCR and BCR sequencing to investigate T- and B-cell clonality in elastase-induced experimental murine abdominal aortic aneurysm.
    Elster C; Ommer-Bläsius M; Lang A; Vajen T; Pfeiler S; Feige M; Yau Pang T; Böttenberg M; Verheyen S; Lê Quý K; Chernigovskaya M; Kelm M; Winkels H; Schmidt SV; Greiff V; Gerdes N
    Front Cardiovasc Med; 2023; 10():1221620. PubMed ID: 38034381
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto's Thyroiditis.
    Cui L; Zhang C; Ding H; Feng D; Huang H; Lu Z; Liu B
    Front Immunol; 2022; 13():821601. PubMed ID: 35720279
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
    Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
    Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Maintenance of the human memory T cell repertoire by subset and tissue site.
    Miron M; Meng W; Rosenfeld AM; Dvorkin S; Poon MML; Lam N; Kumar BV; Louzoun Y; Luning Prak ET; Farber DL
    Genome Med; 2021 Jun; 13(1):100. PubMed ID: 34127056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life.
    Attaf M; Roider J; Malik A; Rius Rafael C; Dolton G; Predergast AJ; Leslie A; Ndung'u T; Kløverpris HN; Sewell AK; Goulder PJ
    Front Immunol; 2020; 11():1587. PubMed ID: 33101265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proportional Tumor Infiltration of T Cells
    Tsunoda M; Aoki H; Shimizu H; Shichino S; Matsushima K; Ueha S
    Front Immunol; 2021; 12():744381. PubMed ID: 34759926
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estimation of T-cell repertoire diversity and clonal size distribution by Poisson abundance models.
    Sepúlveda N; Paulino CD; Carneiro J
    J Immunol Methods; 2010 Feb; 353(1-2):124-37. PubMed ID: 19931272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD.
    Werner L; Lee YN; Rechavi E; Lev A; Yerushalmi B; Ling G; Shah N; Uhlig HH; Weiss B; Somech R; Snapper SB; Shouval DS
    Front Immunol; 2020; 11():109. PubMed ID: 32117262
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer.
    Tamura K; Hazama S; Yamaguchi R; Imoto S; Takenouchi H; Inoue Y; Kanekiyo S; Shindo Y; Miyano S; Nakamura Y; Kiyotani K
    Oncol Lett; 2016 Jun; 11(6):3643-3649. PubMed ID: 27284367
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Normalization of T cell receptor repertoire diversity in patients with advanced colorectal cancer who responded to chemotherapy.
    Luo W; Liao WJ; Huang YT; Shi M; Zhang Y; Wen Q; Zhou MQ; Ma L
    Cancer Sci; 2011 Apr; 102(4):706-12. PubMed ID: 21235683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.